Sodium butyrate inhibits myogenesis by interfering with the transcriptional activation function of MyoD and myogenin.
Sodium butyrate reversibly inhibits muscle differentiation and blocks the expression of many muscle-specific genes in both proliferating myoblasts and differentiated myotubes. We investigated the role of the basic helix-loop-helix (bHLH) myogenic determinator proteins MyoD and myogenin in this inhibition. Our data suggest that both MyoD and myogenin are not able to function as transcriptional activators in the presence of butyrate, although both apparently retain the ability to bind DNA. Transcription of MyoD itself is extinguished in butyrate-treated myoblasts and myotubes, an effect that may be due to the inability of MyoD to autoactivate its own transcription. We present evidence that the HLH region of MyoD is essential for butyrate inhibition of MyoD. In contrast to MyoD and myogenin, butyrate does not inhibit the ubiquitous basic HLH protein E2-5 from functioning as a transcriptional activator.
Johnston
L A
LA
Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.
Tapscott
S J
SJ
Eisen
H
H
D001483:Base Sequence; D002087:Butyrates / Q000494:pharmacology*; D020148:Butyric Acid; D002454:Cell Differentiation / Q000187:drug effects / Q000235:genetics; D002460:Cell Line; D004247:DNA; D005786:Gene Expression Regulation; D008969:Molecular Sequence Data; D009124:Muscle Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics; D009132:Muscles / Q000166:cytology / Q000187:drug effects*; D009154:Mutation; D017570:MyoD Protein; D018008:Myogenin; D009928:Organ Specificity / Q000235:genetics; D011485:Protein Binding; D014157:Transcription Factors / Q000037:antagonists & inhibitors*; D014158:Transcription, Genetic / Q000187:drug effects*
D002087:Butyrates; D009124:Muscle Proteins; D017570:MyoD Protein; D018008:Myogenin; D014157:Transcription Factors; D020148:Butyric Acid; D004247:DNA